| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.346 | 3.944 | 6.571 | 14.484 | 10.769 | 8.867 | 9.477 | 13.428 | 17.345 | 19.400 |
| Total Income - EUR | 3.346 | 3.944 | 6.571 | 57.291 | 34.359 | 8.867 | 9.477 | 13.428 | 17.345 | 19.400 |
| Total Expenses - EUR | 3.068 | 4.187 | 4.430 | 47.276 | 29.995 | 6.503 | 10.686 | 8.191 | 14.727 | 13.485 |
| Gross Profit/Loss - EUR | 278 | -243 | 2.141 | 10.014 | 4.364 | 2.364 | -1.209 | 5.237 | 2.618 | 5.915 |
| Net Profit/Loss - EUR | 178 | -361 | 1.864 | 9.200 | 3.853 | 2.116 | -1.493 | 4.834 | 1.948 | 4.720 |
| Employees | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Terapia Ultramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.602 | 17.129 | 85.578 | 38.705 | 9.610 | 6.802 | 2.544 | 0 | 0 | 33.844 |
| Current Assets | 500 | 189 | 61 | 792 | 4.201 | 3.209 | 1.693 | 5.363 | 4.347 | 5.013 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 752 | 0 | 0 | 0 | 310 | 699 | 3.372 |
| Cash | 500 | 189 | 61 | 40 | 4.201 | 3.209 | 1.693 | 5.053 | 3.648 | 1.642 |
| Shareholders Funds | -1.069 | -1.419 | 468 | 9.660 | 13.326 | 9.814 | 4.060 | 4.882 | 2.970 | 7.674 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.170 | 18.737 | 85.171 | 29.837 | 484 | 197 | 176 | 481 | 1.377 | 31.183 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Terapia Ultramed Srl